Trade

with

Biocryst Pharmaceuticals Inc
(NASDAQ: BCRX)
AdChoices
12.19
+0.49
+4.19%
After Hours :
12.44
+0.25
+2.05%

Open

11.86

Previous Close

11.70

Volume (Avg)

1.18M (1.41M)

Day's Range

11.80-12.45

52Wk Range

4.55-14.62

Market Cap.

874.71M

Dividend Rate ( Yield )

-

Beta

2.14

Shares Outstanding

71.76M

P/E Ratio (EPS)

-

AdChoices
Ownership

Institutional Ownership

75.48%

Top 10 Institutions

61.44%

Mutual Fund Ownership

33.82%

Float

86.65%

5% / Insider Ownership

5.64%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • Fidelity® OTC Portfolio

  •  

    1,582,464

  • 0.00

  • 2.21

  • SPDR® S&P Biotech ETF

  •  

    1,484,350

  • 0.00

  • 2.40

  • Fidelity® Select Health Care Portfolio

  •  

    1,400,000

  • 0.00

  • 1.95

  • Fidelity® Independence Fund

  •  

    1,311,590

  • 0.00

  • 1.83

  • Fidelity® Advisor Small Cap Opps Fund

  •  

    1,289,050

  • 29.03

  • 1.80

  • iShares Russell 2000 (AU)

  •  

    1,078,189

  • -0.90

  • 1.75

  • Vanguard Total Stock Mkt Idx

  •  

    1,029,012

  • 0.00

  • 1.43

  • Fidelity® Select Biotechnology Portfolio

  •  

    965,000

  • 0.00

  • 1.34

  • iShares Nasdaq Biotechnology

  •  

    934,959

  • -1.85

  • 1.51

  • Fidelity® Blue Chip Growth Fund

  •  

    833,700

  • 0.00

  • 1.16

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Baker Bros Advisors LLC

  •  

    10,890,872

  • +85.63%

  • 15.19

  • Fidelity Management and Research Company

  •  

    10,613,025

  • +18.23%

  • 14.80

  • Wellington Management Company, LLP

  •  

    5,349,345

  • +33.08%

  • 7.46

  • RA Capital Management, LLC

  •  

    3,198,529

  • -26.43%

  • 4.46

  • BlackRock Fund Advisors

  •  

    2,558,112

  • +184.83%

  • 3.57

  • RTW INVESTMENTS, LLC

  •  

    2,460,865

  • -9.82%

  • 4.16

  • D. E. Shaw & Co LP

  •  

    2,422,218

  • +17.07%

  • 3.38

  • State Street Corp

  •  

    2,247,454

  • +37.17%

  • 3.13

  • Vanguard Group, Inc.

  •  

    2,049,252

  • +14.83%

  • 2.86

  • VHCP Management, LLC

  •  

    1,744,356

  • 0.00%

  • 2.43

Company Profile

Sector

Healthcare

Industry

Biotechnology

Type

Slow Growth

Style

Small Core

Biocryst Pharmaceuticals Inc. is a Delaware corporation originally founded in 1986. The Company is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. It...more integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. It uses X-ray crystallography, computer modeling of molecular structures and advanced chemistry techniques on the three-dimensional molecular structure and active site characteristics of the enzymes that control cellular biology. The Company’s drug candidates include Peramivir, BCX4161, Two 2nd generation HAE compounds, BCX4430, Forodesine and Ulodesine. Peramiv...moreir is a neuraminidase inhibitor for the treatment of patients with influenza and a potent, intravenously administered antiviral agent that rapidly delivers high plasma concentrations to the sites of infection. BCX4161 is a novel, selective inhibitor of plasma kallikrein in development as an orally-administered treatment for the prevention of attacks in patients with Hereditary Angioedema. Forodesine is a PNP inhibitor in development as a treatment for cancer. Ulodesine is a PNP inhibitor developed as a once-daily oral, chronic treatment for gout. The Company’s product candidates are subject to extensive and rigorous domestic government regulations prior to commercialization.lessless

Key People

Jon P. Stonehouse

CEO/Director/President

Mr. George B. Abercrombie

Chairman of the Board/Director

Thomas R. Staab,II

CFO/Chief Accounting Officer/Senior VP/Treasurer

Ms. Alane Barnes

General Counsel/Secretary/Vice President

Stanley C. Erck

Director

Incorporated

1986

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: